225 related articles for article (PubMed ID: 37686443)
1. Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans.
Permyakova A; Rothner A; Knapp S; Nemirovski A; Ben-Zvi D; Tam J
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686443
[TBL] [Abstract][Full Text] [Related]
2. Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans.
Rothner A; Gov T; Hinden L; Nemirovski A; Tam J; Rosenzweig B
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835635
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox.
Dao M; François H
Front Endocrinol (Lausanne); 2021; 12():720734. PubMed ID: 34305821
[TBL] [Abstract][Full Text] [Related]
4. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss.
Bennetzen MF; Wellner N; Ahmed SS; Ahmed SM; Diep TA; Hansen HS; Richelsen B; Pedersen SB
Int J Obes (Lond); 2011 Nov; 35(11):1377-84. PubMed ID: 21326208
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human.
Buch C; Muller T; Leemput J; Passilly-Degrace P; Ortega-Deballon P; Pais de Barros JP; Vergès B; Jourdan T; Demizieux L; Degrace P
Front Endocrinol (Lausanne); 2021; 12():716431. PubMed ID: 34434170
[TBL] [Abstract][Full Text] [Related]
6. Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the endocannabinoid system in white and brown adipose tissue of weanling rat offspring.
Almeida MM; Dias-Rocha CP; Souza AS; Muros MF; Mendonca LS; Pazos-Moura CC; Trevenzoli IH
Br J Nutr; 2017 Nov; 118(10):788-803. PubMed ID: 29110748
[TBL] [Abstract][Full Text] [Related]
7. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.
Knani I; Earley BJ; Udi S; Nemirovski A; Hadar R; Gammal A; Cinar R; Hirsch HJ; Pollak Y; Gross I; Eldar-Geva T; Reyes-Capo DP; Han JC; Haqq AM; Gross-Tsur V; Wevrick R; Tam J
Mol Metab; 2016 Dec; 5(12):1187-1199. PubMed ID: 27900261
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic endocannabinoids inversely correlate with the development of diet-induced obesity in male and female mice.
Miralpeix C; Fosch A; Casas J; Baena M; Herrero L; Serra D; Rodríguez-Rodríguez R; Casals N
J Lipid Res; 2019 Jul; 60(7):1260-1269. PubMed ID: 31138606
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the hippocampal endocannabinoid system in diet-induced obese mice.
Massa F; Mancini G; Schmidt H; Steindel F; Mackie K; Angioni C; Oliet SH; Geisslinger G; Lutz B
J Neurosci; 2010 May; 30(18):6273-81. PubMed ID: 20445053
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of targeting the peripheral endocannabinoid/CB
Tam J; Hinden L; Drori A; Udi S; Azar S; Baraghithy S
Eur J Intern Med; 2018 Mar; 49():23-29. PubMed ID: 29336868
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
Tam J
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system links gut microbiota to adipogenesis.
Muccioli GG; Naslain D; Bäckhed F; Reigstad CS; Lambert DM; Delzenne NM; Cani PD
Mol Syst Biol; 2010 Jul; 6():392. PubMed ID: 20664638
[TBL] [Abstract][Full Text] [Related]
13. Role of the endocannabinoid system in the regulation of the skeletal muscle response to exercise.
Schönke M; Martinez-Tellez B; Rensen PC
Curr Opin Pharmacol; 2020 Jun; 52():52-60. PubMed ID: 32619926
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the Endocannabinoid System in the Control of Pain and Obesity by Exercise in Rodents: A Systematic Review.
Elisei L; Moraes T; Malta I; Rodríguez J; Di Marzo V; Galdino G
Cannabis Cannabinoid Res; 2023 Jun; 8(3):389-407. PubMed ID: 37040300
[TBL] [Abstract][Full Text] [Related]
15. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.
Matias I; Gonthier MP; Orlando P; Martiadis V; De Petrocellis L; Cervino C; Petrosino S; Hoareau L; Festy F; Pasquali R; Roche R; Maj M; Pagotto U; Monteleone P; Di Marzo V
J Clin Endocrinol Metab; 2006 Aug; 91(8):3171-80. PubMed ID: 16684820
[TBL] [Abstract][Full Text] [Related]
16. Peripheral endocannabinoid system activity in patients treated with sibutramine.
Engeli S; Heusser K; Janke J; Gorzelniak K; Bátkai S; Pacher P; Harvey-White J; Luft FC; Jordan J
Obesity (Silver Spring); 2008 May; 16(5):1135-7. PubMed ID: 18356837
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
[TBL] [Abstract][Full Text] [Related]
18. Dietary PUFAs and Exercise Dynamic Actions on Endocannabinoids in Brain: Consequences for Neural Plasticity and Neuroinflammation.
Park Y; Watkins BA
Adv Nutr; 2022 Oct; 13(5):1989-2001. PubMed ID: 35675221
[TBL] [Abstract][Full Text] [Related]
19. CB
Drori A; Gammal A; Azar S; Hinden L; Hadar R; Wesley D; Nemirovski A; Szanda G; Salton M; Tirosh B; Tam J
Elife; 2020 Nov; 9():. PubMed ID: 33210603
[TBL] [Abstract][Full Text] [Related]
20. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women.
Pastor A; Fernández-Aranda F; Fitó M; Jiménez-Murcia S; Botella C; Fernández-Real JM; Frühbeck G; Tinahones FJ; Fagundo AB; Rodriguez J; Agüera Z; Langohr K; Casanueva FF; de la Torre R
PLoS One; 2016; 11(2):e0148734. PubMed ID: 26849214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
